Neurological Biomarkers Market Report by Type (Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers, and Others), Application (Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, Autism Spectrum Disorders, and Others), End Use (Hospital Laboratories, Clinical Diagnostic Centers, Research Organizations, and Others), and Region 2024-2032

Neurological Biomarkers Market Report by Type (Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers, and Others), Application (Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, Autism Spectrum Disorders, and Others), End Use (Hospital Laboratories, Clinical Diagnostic Centers, Research Organizations, and Others), and Region 2024-2032

Report Format: PDF+Excel | Report ID: SR112024A3181
Buy Now

1   Preface
2   Scope and Methodology

    2.1   Objectives of the Study
    2.2   Stakeholders
    2.3   Data Sources
        2.3.1   Primary Sources
        2.3.2   Secondary Sources
    2.4   Market Estimation
        2.4.1   Bottom-Up Approach
        2.4.2   Top-Down Approach
    2.5   Forecasting Methodology
3   Executive Summary
4   Introduction

    4.1   Overview
    4.2   Key Industry Trends
5   Global Neurological Biomarkers Market
    5.1   Market Overview
    5.2   Market Performance
    5.3   Impact of COVID-19
    5.4   Market Forecast
6    Market Breakup by Type
     6.1   Genomic Biomarkers
        6.1.1 Market Trends
        6.1.2 Market Forecast
     6.2   Proteomic Biomarkers
        6.2.1 Market Trends
        6.2.2 Market Forecast
     6.3   Metabolomic Biomarkers
        6.3.1 Market Trends
        6.3.2 Market Forecast
     6.4   Imaging Biomarkers
        6.4.1 Market Trends
        6.4.2 Market Forecast
     6.5   Others
        6.5.1 Market Trends
        6.5.2 Market Forecast
7    Market Breakup by Application
     7.1   Alzheimer's Disease
        7.1.1 Market Trends
        7.1.2 Market Forecast
     7.2   Parkinson's Disease
        7.2.1 Market Trends
        7.2.2 Market Forecast
     7.3   Multiple Sclerosis
        7.3.1 Market Trends
        7.3.2 Market Forecast
     7.4   Autism Spectrum Disorders
        7.4.1 Market Trends
        7.4.2 Market Forecast
     7.5   Others
        7.5.1 Market Trends
        7.5.2 Market Forecast
8    Market Breakup by End Use
     8.1   Hospital Laboratories
        8.1.1 Market Trends
        8.1.2 Market Forecast
     8.2   Clinical Diagnostic Centers
        8.2.1 Market Trends
        8.2.2 Market Forecast
     8.3   Research Organizations
        8.3.1 Market Trends
        8.3.2 Market Forecast
     8.4   Others
        8.4.1 Market Trends
        8.4.2 Market Forecast
9    Market Breakup by Region
     9.1   North America
          9.1.1   United States
               9.1.1.1 Market Trends
               9.1.1.2 Market Forecast
          9.1.2   Canada
               9.1.2.1 Market Trends
               9.1.2.2 Market Forecast
     9.2   Asia-Pacific
          9.2.1   China
               9.2.1.1 Market Trends
               9.2.1.2 Market Forecast
          9.2.2   Japan
               9.2.2.1 Market Trends
               9.2.2.2 Market Forecast
          9.2.3   India
               9.2.3.1 Market Trends
               9.2.3.2 Market Forecast
          9.2.4   South Korea
               9.2.4.1 Market Trends
               9.2.4.2 Market Forecast
          9.2.5   Australia
               9.2.5.1 Market Trends
               9.2.5.2 Market Forecast
          9.2.6   Indonesia
               9.2.6.1 Market Trends
               9.2.6.2 Market Forecast
          9.2.7   Others
               9.2.7.1 Market Trends
               9.2.7.2 Market Forecast
     9.3   Europe
          9.3.1   Germany
               9.3.1.1 Market Trends
               9.3.1.2 Market Forecast
          9.3.2   France
               9.3.2.1 Market Trends
               9.3.2.2 Market Forecast
          9.3.3   United Kingdom
               9.3.3.1 Market Trends
               9.3.3.2 Market Forecast
          9.3.4   Italy
               9.3.4.1 Market Trends
               9.3.4.2 Market Forecast
          9.3.5   Spain
               9.3.5.1 Market Trends
               9.3.5.2 Market Forecast
          9.3.6   Russia
               9.3.6.1 Market Trends
               9.3.6.2 Market Forecast
          9.3.7   Others
               9.3.7.1 Market Trends
               9.3.7.2 Market Forecast
     9.4   Latin America
          9.4.1   Brazil
               9.4.1.1 Market Trends
               9.4.1.2 Market Forecast
          9.4.2   Mexico
               9.4.2.1 Market Trends
               9.4.2.2 Market Forecast
          9.4.3   Others
               9.4.3.1 Market Trends
               9.4.3.2 Market Forecast
     9.5   Middle East and Africa
          9.5.1 Market Trends
          9.5.2 Market Breakup by Country
          9.5.3 Market Forecast
10  SWOT Analysis
    10.1   Overview
    10.2   Strengths
    10.3   Weaknesses
    10.4   Opportunities
    10.5   Threats
11  Value Chain Analysis
12  Porters Five Forces Analysis

    12.1   Overview
    12.2   Bargaining Power of Buyers
    12.3   Bargaining Power of Suppliers
    12.4   Degree of Competition
    12.5   Threat of New Entrants
    12.6   Threat of Substitutes
13  Price Analysis
14  Competitive Landscape

    14.1   Market Structure
    14.2   Key Players
    14.3   Profiles of Key Players
         14.3.1   Abbott Laboratories
              14.3.1.1   Company Overview
              14.3.1.2   Product Portfolio
              14.3.1.3   Financials
              14.3.1.4   SWOT Analysis
         14.3.2   Acumen Pharmaceuticals Inc.
              14.3.2.1   Company Overview
              14.3.2.2   Product Portfolio
         14.3.3   Athena Diagnostics (Quest Diagnostics)
              14.3.3.1   Company Overview
              14.3.3.2   Product Portfolio
         14.3.4   Banyan Biomarkers Inc.
              14.3.4.1   Company Overview
              14.3.4.2   Product Portfolio
         14.3.5   Bio-Rad Laboratories Inc.
              14.3.5.1   Company Overview
              14.3.5.2   Product Portfolio
              14.3.5.3   Financials
              14.3.5.4   SWOT Analysis
         14.3.6   Immunarray Pvt. Ltd.
              14.3.6.1   Company Overview
              14.3.6.2   Product Portfolio
         14.3.7   Myriad Rbm Inc. (Myriad Genetics Inc.)
              14.3.7.1   Company Overview
              14.3.7.2   Product Portfolio
         14.3.8   Proteome Sciences Plc
              14.3.8.1   Company Overview
              14.3.8.2   Product Portfolio
              14.3.8.3   Financials
              14.3.8.4   SWOT Analysis
         14.3.9   Thermo Fisher Scientific Inc.
              14.3.9.1   Company Overview
              14.3.9.2   Product Portfolio
              14.3.9.3   Financials
              14.3.9.4   SWOT Analysis

List of Figures

Figure 1: Global: Neurological Biomarkers Market: Major Drivers and Challenges
Figure 2: Global: Neurological Biomarkers Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Neurological Biomarkers Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Neurological Biomarkers Market: Breakup by Type (in %), 2023
Figure 5: Global: Neurological Biomarkers Market: Breakup by Application (in %), 2023
Figure 6: Global: Neurological Biomarkers Market: Breakup by End Use (in %), 2023
Figure 7: Global: Neurological Biomarkers Market: Breakup by Region (in %), 2023
Figure 8: Global: Neurological Biomarkers (Genomic Biomarkers) Market: Sales Value (in Million US$), 2018 & 2023
Figure 9: Global: Neurological Biomarkers (Genomic Biomarkers) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 10: Global: Neurological Biomarkers (Proteomic Biomarkers) Market: Sales Value (in Million US$), 2018 & 2023
Figure 11: Global: Neurological Biomarkers (Proteomic Biomarkers) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 12: Global: Neurological Biomarkers (Metabolomic Biomarkers) Market: Sales Value (in Million US$), 2018 & 2023
Figure 13: Global: Neurological Biomarkers (Metabolomic Biomarkers) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 14: Global: Neurological Biomarkers (Imaging Biomarkers) Market: Sales Value (in Million US$), 2018 & 2023
Figure 15: Global: Neurological Biomarkers (Imaging Biomarkers) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 16: Global: Neurological Biomarkers (Others) Market: Sales Value (in Million US$), 2018 & 2023
Figure 17: Global: Neurological Biomarkers (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 18: Global: Neurological Biomarkers (Alzheimer's Disease) Market: Sales Value (in Million US$), 2018 & 2023
Figure 19: Global: Neurological Biomarkers (Alzheimer's Disease) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 20: Global: Neurological Biomarkers (Parkinson's Disease) Market: Sales Value (in Million US$), 2018 & 2023
Figure 21: Global: Neurological Biomarkers (Parkinson's Disease) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 22: Global: Neurological Biomarkers (Multiple Sclerosis) Market: Sales Value (in Million US$), 2018 & 2023
Figure 23: Global: Neurological Biomarkers (Multiple Sclerosis) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 24: Global: Neurological Biomarkers (Autism Spectrum Disorders) Market: Sales Value (in Million US$), 2018 & 2023
Figure 25: Global: Neurological Biomarkers (Autism Spectrum Disorders) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 26: Global: Neurological Biomarkers (Others) Market: Sales Value (in Million US$), 2018 & 2023
Figure 27: Global: Neurological Biomarkers (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 28: Global: Neurological Biomarkers (Hospital Laboratories) Market: Sales Value (in Million US$), 2018 & 2023
Figure 29: Global: Neurological Biomarkers (Hospital Laboratories) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 30: Global: Neurological Biomarkers (Clinical Diagnostic Centers) Market: Sales Value (in Million US$), 2018 & 2023
Figure 31: Global: Neurological Biomarkers (Clinical Diagnostic Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 32: Global: Neurological Biomarkers (Research Organizations) Market: Sales Value (in Million US$), 2018 & 2023
Figure 33: Global: Neurological Biomarkers (Research Organizations) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 34: Global: Neurological Biomarkers (Others) Market: Sales Value (in Million US$), 2018 & 2023
Figure 35: Global: Neurological Biomarkers (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 36: North America: Neurological Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 37: North America: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 38: United States: Neurological Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 39: United States: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 40: Canada: Neurological Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 41: Canada: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 42: Asia-Pacific: Neurological Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 43: Asia-Pacific: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 44: China: Neurological Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 45: China: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 46: Japan: Neurological Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 47: Japan: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 48: India: Neurological Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 49: India: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 50: South Korea: Neurological Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 51: South Korea: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 52: Australia: Neurological Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 53: Australia: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 54: Indonesia: Neurological Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 55: Indonesia: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 56: Others: Neurological Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 57: Others: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 58: Europe: Neurological Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 59: Europe: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 60: Germany: Neurological Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 61: Germany: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 62: France: Neurological Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 63: France: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 64: United Kingdom: Neurological Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 65: United Kingdom: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 66: Italy: Neurological Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 67: Italy: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 68: Spain: Neurological Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 69: Spain: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 70: Russia: Neurological Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 71: Russia: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 72: Others: Neurological Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 73: Others: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 74: Latin America: Neurological Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 75: Latin America: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 76: Brazil: Neurological Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 77: Brazil: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 78: Mexico: Neurological Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 79: Mexico: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 80: Others: Neurological Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 81: Others: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 82: Middle East and Africa: Neurological Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 83: Middle East and Africa: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 84: Middle East and Africa: Neurological Biomarkers Market: Breakup by Country (in %), 2023
Figure 85: Global: Neurological Biomarkers Industry: SWOT Analysis
Figure 86: Global: Neurological Biomarkers Industry: Value Chain Analysis
Figure 87: Global: Neurological Biomarkers Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Neurological Biomarkers Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Neurological Biomarkers Market Forecast: Breakup by Type (in Million US$), 2024-2032
Table 3: Global: Neurological Biomarkers Market Forecast: Breakup by Application (in Million US$), 2024-2032
Table 4: Global: Neurological Biomarkers Market Forecast: Breakup by End Use (in Million US$), 2024-2032
Table 5: Global: Neurological Biomarkers Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 6: Global: Neurological Biomarkers Market: Competitive Structure
Table 7: Global: Neurological Biomarkers Market: Key Players

Neurological Biomarkers Market Report by Type (Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers, and Others), Application (Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, Autism Spectrum Disorders, and Others), End Use (Hospital Laboratories, Clinical Diagnostic Centers, Research Organizations, and Others), and Region 2024-2032
Purchase options




Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-713-2163

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More